SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Clinical trial NCT00180453 · COMPLETED

Trial details

NCT number: NCT00180453
Sponsor: Abbott Medical Devices
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease Everolimus Vascular Disease Myocardial Ischemia Coronary Artery Stenosis

Start date: 2003-12-01
Primary completion: 2005-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.